New hope for IBS sufferers: gelsectan trial launches in vietnam

This study tests whether Gelsectan, a supplement that coats the gut, can reduce diarrhea, belly pain, and bloating in people with diarrhea-predominant irritable bowel syndrome (IBS-D). About 90 adults in Vietnam will be randomly assigned to take Gelsectan alone, Gelsectan plus a standard antispasmodic drug, or the drug alone for two months. Researchers will track symptom changes and side effects to see if Gelsectan offers better relief than standard care.